newsfilter
← Latest News
GlobeNewswire·

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

WAYNE, Pa., July 07, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated